Not applicableStudy completedNCT02221661
What this trial is testing
Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center
Who this might be right for
Cognitive ImpairmentMemory ComplaintClinical Investigation in Memory Centers
Diaxonhit 606